Work

Outcomes of patients with malignant melanoma treated with immunotherapy prior to or after vemurafenib.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8569

Authors: Allison Ackerman, David F. McDermott, Donald P. Lawrence, Anasuya Gunturi, Keith T. Flaherty, Anita Giobbie-Hurder, F. Stephen Hodi, Nageatte Ibrahim, Michael B. Atkins, Daniel C. Cho, Ryan J. Sullivan

Institutions: Beth Israel Deaconess Medical Center, Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2274069028

Cites:

Cited by: 33

Related to: 10